To ask the Secretary of State for Business and Trade, what mechanisms within the UK-US Economic Prosperity Deal will ensure that pharmaceutical products launched in the UK with a lower price than in the US will not trigger Most Favoured Nation rebates.
We have secured the first and only deal with the US that delivers zero percent tariffs on pharmaceutical products – the lowest rate offered to any country. It delivers mitigations on the US’ ‘Most Favoured Nation’ policy and preferential terms for UK medt...
Drugs: USA